Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bogdan Batko

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Environmental Research and Public Health|December 11, 2022
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis PatientsMateusz Moskal, Piotr Krawiec, Wojciech Zaręba, et al.
Expert Opinion on Biological Therapy|April 23, 2026
Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group studyHonghu Tang, Eva Dokoupilova, Bogdan Batko, et al.
Reumatologia|October 24, 2017
Diagnostic delays in rheumatic diseases with associated arthritisFilip Raciborski, Anna Kłak, Brygida Kwiatkowska, et al.
Reumatologia|February 7, 2024
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt riskAnna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, et al.
Przeglad Lekarski|October 14, 2006
[Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus]Piotr Krawiec, Bogdan Batko, Antoni Skura, et al.
Clinical Rheumatology|May 12, 2019
Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritisBogdan Batko, Karol Urbański, Jerzy Świerkot, et al.
Rheumatology and Therapy|July 26, 2024
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL SurveillanceBogdan Batko, Slawomir Jeka, Piotr Wiland, et al.
Reumatologia|September 22, 2018
Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for RheumatologyEugeniusz J Kucharz, Marcin Stajszczyk, Anna Kotulska-Kucharz, et al.
Rheumatology International|September 2, 2025
Psoriatic arthritis incidence and prevalence trajectory in Poland-public-payer, national-level, long-term dataMagdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, et al.
Scientific Reports|September 6, 2018
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatmentBogdan Batko, Pawel Maga, Karol Urbanski, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Environmental Research and Public Health|December 11, 2022
Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis PatientsMateusz Moskal, Piotr Krawiec, Wojciech Zaręba, et al.
Expert Opinion on Biological Therapy|April 23, 2026
Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group studyHonghu Tang, Eva Dokoupilova, Bogdan Batko, et al.
Reumatologia|October 24, 2017
Diagnostic delays in rheumatic diseases with associated arthritisFilip Raciborski, Anna Kłak, Brygida Kwiatkowska, et al.
Reumatologia|February 7, 2024
Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt riskAnna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, et al.
Przeglad Lekarski|October 14, 2006
[Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus]Piotr Krawiec, Bogdan Batko, Antoni Skura, et al.
Clinical Rheumatology|May 12, 2019
Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritisBogdan Batko, Karol Urbański, Jerzy Świerkot, et al.
Rheumatology and Therapy|July 26, 2024
Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL SurveillanceBogdan Batko, Slawomir Jeka, Piotr Wiland, et al.
Reumatologia|September 22, 2018
Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for RheumatologyEugeniusz J Kucharz, Marcin Stajszczyk, Anna Kotulska-Kucharz, et al.
Rheumatology International|September 2, 2025
Psoriatic arthritis incidence and prevalence trajectory in Poland-public-payer, national-level, long-term dataMagdalena Krajewska-Włodarczyk, Mateusz Szeląg, Bogdan Batko, et al.
Scientific Reports|September 6, 2018
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatmentBogdan Batko, Pawel Maga, Karol Urbanski, et al.
Pageof 6